it doesn't have to be exactly 2:1, it's not like it's some threshhold to be broken. It's a guideline. I'm interested to see how dilute we are now, but if we're around 1 bill, who cares how exact with the acquisitions we made. All about what those produce now. Either a good deal diluting or not.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links